As on Wednesday, Perspective Therapeutics Inc (AMEX: CATX) got off with the flyer as it spiked 11.24% to $3.86, before settling in for the price of $3.47 at the close. Taking a more long-term approach, CATX posted a 52-week range of $1.60-$13.44.
It was noted that the giant of the Healthcare sector posted annual sales growth of -9.86% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -9.86%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 3.61%. This publicly-traded company’s shares outstanding now amounts to $74.26 million, simultaneously with a float of $60.73 million. The organization now has a market capitalization sitting at $286.65 million. At the time of writing, stock’s 50-day Moving Average stood at $3.52, while the 200-day Moving Average is $3.12.
Perspective Therapeutics Inc (CATX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Devices industry. Perspective Therapeutics Inc’s current insider ownership accounts for 18.23%, in contrast to 66.80% institutional ownership. According to the most recent insider trade that took place on Mar 28 ’25, this organization’s Chief Executive Officer bought 22,026 shares at the rate of 2.24, making the entire transaction reach 49,384 in total value, affecting insider ownership by 59,383. Preceding that transaction, on Mar 28 ’25, Company’s Chief Executive Officer bought 4,650 for 2.21, making the whole transaction’s value amount to 10,288. This particular insider is now the holder of 4,650 in total.
Perspective Therapeutics Inc (CATX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
Perspective Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 3.61% and is forecasted to reach -1.34 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -1.87% through the next 5 years, which can be compared against the -9.86% growth it accomplished over the previous five years trading on the market.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Let’s observe the current performance indicators for Perspective Therapeutics Inc (CATX). It’s Quick Ratio in the last reported quarter now stands at 15.09. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 231.17.
In the same vein, CATX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.32, a figure that is expected to reach -0.32 in the next quarter, and analysts are predicting that it will be -1.34 at the market close of one year from today.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Through scrutinizing the latest numbers posted by the [Perspective Therapeutics Inc, CATX], it can be observed that its last 5-days Average volume of 0.81 million was lower the volume of 0.91 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 70.30% While, its Average True Range was 67.98.
Raw Stochastic average of Perspective Therapeutics Inc (CATX) in the period of the previous 100 days is set at 66.09%, which indicates a major fall in contrast to 96.34% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.22 that was lower than 0.29 volatility it exhibited in the past 100-days period.
